Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.

Matéria original

Anterior

Covid-19 post-infectious acute transverse myelitis responsive to corticosteroid therapy: report of two clinical cases

Próxima

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting